137 related articles for article (PubMed ID: 38476635)
1. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D.
Mohan S; Sheehan M; Tebben P; Wermers R
JCEM Case Rep; 2024 Mar; 2(3):luae022. PubMed ID: 38476635
[TBL] [Abstract][Full Text] [Related]
2. Hypervitaminosis D Secondary to a
Collins L; Boehm E; Luxford C; Clifton-Bligh R; Grill V
JBMR Plus; 2023 Sep; 7(9):e10788. PubMed ID: 37701149
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
O'Keeffe DT; Tebben PJ; Kumar R; Singh RJ; Wu Y; Wermers RA
Osteoporos Int; 2016 Oct; 27(10):3121-5. PubMed ID: 27129455
[TBL] [Abstract][Full Text] [Related]
6. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
8. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
Carpenter TO
J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
[TBL] [Abstract][Full Text] [Related]
9. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations.
Shah AD; Hsiao EC; O'Donnell B; Salmeen K; Nussbaum R; Krebs M; Baumgartner-Parzer S; Kaufmann M; Jones G; Bikle DD; Wang Y; Mathew AS; Shoback D; Block-Kurbisch I
J Clin Endocrinol Metab; 2015 Aug; 100(8):2832-6. PubMed ID: 26097993
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
12. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
13. Hyperparathyroidism complicating CYP 24A1 mutations.
Loyer C; Leroy C; Molin A; Odou MF; Huglo D; Lion G; Ernst O; Hoffmann M; Porchet N; Carnaille B; Pattou F; Kottler ML; Vantyghem MC
Ann Endocrinol (Paris); 2016 Oct; 77(5):615-619. PubMed ID: 27378451
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report.
Faiq S; Lavelle K; Hu T; Shoback D; Ku G
BMC Endocr Disord; 2023 Jun; 23(1):133. PubMed ID: 37328745
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature.
Shah R; Licata A; Oyesiku NM; Ioachimescu AG
Pituitary; 2012 Dec; 15 Suppl 1():S17-22. PubMed ID: 21188640
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
Mahajan A; Buse J; Kline G
Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
[TBL] [Abstract][Full Text] [Related]
17. Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the
Cappellani D; Brancatella A; Kaufmann M; Minucci A; Vignali E; Canale D; De Paolis E; Capoluongo E; Cetani F; Jones G; Marcocci C
Case Rep Endocrinol; 2019; 2019():4982621. PubMed ID: 31089432
[TBL] [Abstract][Full Text] [Related]
18. Rifampin monotherapy for children with idiopathic infantile hypercalcemia.
Lenherr-Taube N; Furman M; Assor E; Thummel K; Levine MA; Sochett E
J Steroid Biochem Mol Biol; 2023 Jul; 231():106301. PubMed ID: 36990163
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual.
Haridas K; Holick MF; Burmeister LA
Nutrition; 2020 Jun; 74():110754. PubMed ID: 32222584
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]